AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33328395 — intervention group
Group type: EXPERIMENTAL
Intervention: Aging (24h or 1y)
Number of subjects: 96
Study 32869576 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiao xingnao kaiqiao acupuncture, once daily for 21 days, needles retained for 30 min.
Number of subjects: 90
Study 32869576 — intervention group
Group type: COMPARATOR
Intervention: Flunarizine Hydrochloride, 5 mg, once daily for 21 days.
Number of subjects: 90
Study 34840045 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Park's submucosal hemorrhoidectomy (MPSH)
Number of subjects: 186
Study 34840045 — intervention group
Group type: COMPARATOR
Intervention: Milligan-Morgan hemorrhoidectomy (MMH)
Number of subjects: 186
Study 32861015 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBTI), 4 sessions of behavioral therapy
Number of subjects: 25
Study 32861015 — intervention group
Group type: COMPARATOR
Intervention: Non-CBTI group, 1 informative session on sleep hygiene
Number of subjects: 25
Study 34417368 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin
Number of subjects: 379
Study 34417368 — intervention group
Group type: COMPARATOR
Intervention: Crystalloids
Number of subjects: 379
Study 33322678 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt-60
Number of subjects: 56
Study 33322678 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt-30
Number of subjects: 56
Study 33322678 — intervention group
Group type: COMPARATOR
Intervention: No-Prompt Comparison
Number of subjects: 56
Study 36395030 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Project
Number of subjects: 168
Study 36395030 — intervention group
Group type: EXPERIMENTAL
Intervention: Media psychoeducation (active control)
Number of subjects: 168
Study 36395030 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 168
Study 34081399 — intervention group
Group type: EXPERIMENTAL
Intervention: MiMiC (computational approach for data-driven design of simplified communities)
Number of subjects: 937
Study 34081399 — intervention group
Group type: EXPERIMENTAL
Intervention: MiMiC
Number of subjects: 937
Study 32420830 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary habits including drinking pure fruit juice, consuming more meat with less visible fat, and modest salt consumption during cooking
Number of subjects: 200
Study 32420830 — intervention group
Group type: COMPARATOR
Intervention: Control group (without POAG)
Number of subjects: 200
Study 36458932 — intervention group
Group type: EXPERIMENTAL
Intervention: ONRC (non-regenerated oxidized cellulose)
Number of subjects: 0
Study 36458932 — intervention group
Group type: COMPARATOR
Intervention: ORC (regenerated oxidized cellulose)
Number of subjects: 0
Study 36458932 — intervention group
Group type: EXPERIMENTAL
Intervention: ONRC
Number of subjects: 0
Study 36458932 — intervention group
Group type: COMPARATOR
Intervention: ORC
Number of subjects: 0
Study 32668505 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid-sparing antiemetic protocol using olanzapine (group 2)
Number of subjects: 108
Study 32668505 — intervention group
Group type: COMPARATOR
Intervention: Steroid-containing antiemetic protocol (group 1)
Number of subjects: 108
Study 32668505 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 108
Study 34380355 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-exaggeration condition (ES group; n=46)
Number of subjects: 84
Study 34380355 — intervention group
Group type: COMPARATOR
Intervention: Simulation-only condition (S group; n=38)
Number of subjects: 84
Study 36459044 — intervention group
Group type: EXPERIMENTAL
Intervention: Benson's relaxation therapy (BRT) plus aerobic exercise (5 sessions per week) for 8 weeks
Number of subjects: 60
Study 36459044 — intervention group
Group type: COMPARATOR
Intervention: Benson's relaxation therapy (BRT) only for 8 weeks
Number of subjects: 60
Study 35675149 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryo-Radial (1-3 cryobiopsies + at least one R-EBUS biopsy via 2.6 mm Guide Sheath)
Number of subjects: 48
Study 35675149 — intervention group
Group type: COMPARATOR
Intervention: CT-TTB (CT-guided transthoracic biopsy)
Number of subjects: 48
Study 36277007 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemp cotton sanitary pads
Number of subjects: 1002
Study 36277007 — intervention group
Group type: COMPARATOR
Intervention: Control group (two types of cotton sanitary pads)
Number of subjects: 1002
Study 33599720 — intervention group
Group type: EXPERIMENTAL
Intervention: Ontamalimab 75 mg every 4 weeks for 72 weeks (OL1)
Number of subjects: 330
Study 33599720 — intervention group
Group type: EXPERIMENTAL
Intervention: Ontamalimab 225 mg every 4 weeks for 72 weeks (OL1)
Number of subjects: 330
Study 33599720 — intervention group
Group type: EXPERIMENTAL
Intervention: Ontamalimab (combined data from both doses)
Number of subjects: 330
Study 33599720 — intervention group
Group type: COMPARATOR
Intervention: Placebo (from TURANDOT study)
Number of subjects: 330
Study 33147220 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acids-mineral complexed (AACM) diet with 40, 40 and 2.75 mg/kg of Zn, Mn and Cu, respectively, plus 30, 30 and 5.25 mg/kg of Zn, Mn and Cu from AACM sources
Number of subjects: 800
Study 33147220 — intervention group
Group type: COMPARATOR
Intervention: Inorganic minerals (IM) diet with 70, 70 and 8 mg/kg of Zn, Mn and Cu, respectively
Number of subjects: 800
Study 35385072 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (266 mg) + bupivacaine hydrochloride (100 mg)
Number of subjects: 533
Study 35385072 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine hydrochloride (100 mg) alone
Number of subjects: 533
Study 33834505 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led, face-to-face, individually-tailored health coaching intervention (4-6 sessions covering six core activation topics)
Number of subjects: 118
Study 33834505 — intervention group
Group type: COMPARATOR
Intervention: Usual primary care (control group)
Number of subjects: 118
Study 35107614 — intervention group
Group type: EXPERIMENTAL
Intervention: Working Memory (WM) training
Number of subjects: 89
Study 35107614 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 89
Study 32232971 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive intervention based on SMS
Number of subjects: 4501
Study 32232971 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4501
Study 32737085 — intervention group
Group type: EXPERIMENTAL
Intervention: Transgender Education for Affirmative and Competent HIV and Healthcare intervention (TEACHH) workshops
Number of subjects: 150
Study 35084369 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (300 mg nightly for 3 days and then 300 mg twice a day for 11 days)
Number of subjects: 39
Study 35084369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 33517103 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea extract (GTE)
Number of subjects: 194
Study 33517103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study 36289541 — intervention group
Group type: EXPERIMENTAL
Intervention: IMMENSE intervention (clinical pharmacist intervention)
Number of subjects: 480
Study 36289541 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 480
Study 36289541 — intervention group
Group type: EXPERIMENTAL
Intervention: IMMENSE intervention
Number of subjects: 480
Study 32043558 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal rehabilitation pathway (MRP) consisting of epileptological follow-up, neurocognitive training, emotional support, and social support
Number of subjects: 33
Study 32043558 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal rehabilitation pathway (MRP)
Number of subjects: 33
Study 35701314 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive pharmaceutical care intervention added to cardiac rehabilitation program
Number of subjects: 40
Study 35701314 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard cardiac rehabilitation program)
Number of subjects: 40
Study 32818931 — intervention group
Group type: EXPERIMENTAL
Intervention: Early human albumin solution (HAS)
Number of subjects: 1464
Study 34032500 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic urethral recurrence (UR)
Number of subjects: 144
Study 34032500 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic urethral recurrence (UR)
Number of subjects: 144
Study 34032500 — intervention group
Group type: EXPERIMENTAL
Intervention: Urethral recurrence (UR)
Number of subjects: 144
Study 34032500 — intervention group
Group type: COMPARATOR
Intervention: Carcinoma in situ
Number of subjects: 144
Study 34032500 — intervention group
Group type: COMPARATOR
Intervention: Multifocal disease
Number of subjects: 144
Study 34032500 — intervention group
Group type: COMPARATOR
Intervention: Prostatic urethral involvement at RC
Number of subjects: 144
Study 32645095 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching program (SS) performed once a week
Number of subjects: 24
Study 32645095 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching program (SS) performed three times a week
Number of subjects: 24
Study 35158064 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day preoperative application of benzoyl peroxide-miconazole nitrate cream
Number of subjects: 60
Study 35158064 — intervention group
Group type: COMPARATOR
Intervention: No cream (control group)
Number of subjects: 60
Study 32747206 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous meal administration
Number of subjects: 8
Study 35968751 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine 0 μg/kg (Control group)
Number of subjects: 100
Study 35968751 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.6 μg/kg (D1 group)
Number of subjects: 100
Study 35968751 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.8 μg/kg (D2 group)
Number of subjects: 100
Study 35968751 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1.0 μg/kg (D3 group)
Number of subjects: 100
Study 33689254 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided postpyloric feeding tube placement
Number of subjects: 115
Study 33689254 — intervention group
Group type: COMPARATOR
Intervention: Blind postpyloric feeding tube placement
Number of subjects: 115
Study 32955051 — intervention group
Group type: EXPERIMENTAL
Intervention: MCN/BIF-20 composite for solid phase extraction
Number of subjects: 0
Study 35283163 — intervention group
Group type: EXPERIMENTAL
Intervention: incobotulinumtoxinA
Number of subjects: 15
Study 35283163 — intervention group
Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA
Number of subjects: 15
Study 33427129 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback intervention (6 training sessions, once a week)
Number of subjects: 36
Study 33427129 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 36
Study 36283240 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) therapy
Number of subjects: 44
Study 36283240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 34959932 — intervention group
Group type: EXPERIMENTAL
Intervention: Astaxanthin (12 mg once daily for 12 weeks)
Number of subjects: 53
Study 34959932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 33005007 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal SO2 exposure (per 10 μg/m3 increase)
Number of subjects: 1457
Study 33005007 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal SO2 exposure (highest versus lowest quartile)
Number of subjects: 1457
Study 33005007 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal SO2 exposure (high versus low exposure analyses)
Number of subjects: 1457
Study 33020985 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and commitment therapy-enhanced cognitive behavioural therapy for insomnia
Number of subjects: 32
Study 33020985 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 32
Study 36084965 — intervention group
Group type: EXPERIMENTAL
Intervention: allo‐hBM‐MSCDs (1 mL, 2 doses)
Number of subjects: 28
Study 36084965 — intervention group
Group type: EXPERIMENTAL
Intervention: allo‐hBM‐MSCs (1 × 10^6 cells, 1 dose)
Number of subjects: 28
Study 36084965 — intervention group
Group type: COMPARATOR
Intervention: PolyMem dressing (conventional treatment)
Number of subjects: 28
Study 33941122 — intervention group
Group type: EXPERIMENTAL
Intervention: Parsplana vitrectomy plus phacoemulsification (phacovitrectomy, PCV, group B)
Number of subjects: 59
Study 33941122 — intervention group
Group type: COMPARATOR
Intervention: Parsplana vitrectomy alone (group A)
Number of subjects: 59
Study 33278328 — intervention group
Group type: EXPERIMENTAL
Intervention: JZP-458 (25 mg/m2 i.m. and 37.5 mg/m2 i.v.)
Number of subjects: 100
Study 33278328 — intervention group
Group type: EXPERIMENTAL
Intervention: JZP-458 (i.m. injection)
Number of subjects: 100
Study 33278328 — intervention group
Group type: EXPERIMENTAL
Intervention: JZP-458 (all dose levels)
Number of subjects: 100
Study 34714289 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac suppository
Number of subjects: 171
Study 34714289 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer Lactate (RL)
Number of subjects: 171
Study 34714289 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of rectal diclofenac and RL
Number of subjects: 171
Study 34714289 — intervention group
Group type: COMPARATOR
Intervention: Control (individual therapy)
Number of subjects: 171
Study 32047011 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic approach to screening for depression and assessing patient preferences for depression care.
Number of subjects: 1992
Study 32047011 — intervention group
Group type: COMPARATOR
Intervention: Usual care (standard care) provided by general practitioners.
Number of subjects: 1992
Study 35389229 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 0
Study 35389229 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 0
Study 35389229 — intervention group
Group type: EXPERIMENTAL
Intervention: Major bleeding
Number of subjects: 0
Study 35389229 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivial bleeding
Number of subjects: 0
Study 34872630 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized post-coercion review
Number of subjects: 109
Study 34872630 — intervention group
Group type: COMPARATOR
Intervention: Control group (treated as usual)
Number of subjects: 109
Study 33264387 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Rehabilitation (CR) interventions
Number of subjects: 126
Study 32668483 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 39
Study 32668483 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 75 mg once daily
Number of subjects: 39
Study 35491539 — intervention group
Group type: EXPERIMENTAL
Intervention: Single ascending dose of Youkenafil Hydrochloride (25, 50, 100, 150, or 200 mg)
Number of subjects: 0
Study 35491539 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of Youkenafil Hydrochloride (50, 100, or 150 mg once daily for 7 consecutive days)
Number of subjects: 0
Study 35491539 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of Youkenafil Hydrochloride (50 mg) with food
Number of subjects: 0
Study 35491539 — intervention group
Group type: EXPERIMENTAL
Intervention: Single and multiple doses of Youkenafil Hydrochloride (up to 200 mg single dose and up to 150 mg multiple doses)
Number of subjects: 0
Study 34191395 — intervention group
Group type: EXPERIMENTAL
Intervention: Vericiguat
Number of subjects: 5010
Study 34191395 — intervention group
Group type: COMPARATOR
Intervention: No AF
Number of subjects: 5010
Study 32264825 — intervention group
Group type: EXPERIMENTAL
Intervention: Gift exchange at the beginning of the task
Number of subjects: 28
Study 32264825 — intervention group
Group type: COMPARATOR
Intervention: Gift exchange halfway through the task
Number of subjects: 28
Study 33813524 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation program (12-week brisk walking and diet education)
Number of subjects: 44
Study 32603956 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (n = 29)
Number of subjects: 60
Study 32603956 — intervention group
Group type: COMPARATOR
Intervention: Saline control (n = 31)
Number of subjects: 60
Study 34051919 — intervention group
Group type: EXPERIMENTAL
Intervention: Social-Emotional Learning Foundations (SELF) intervention
Number of subjects: 1154
Study 34051919 — intervention group
Group type: COMPARATOR
Intervention: Business as Usual (BAU)
Number of subjects: 1154
Study 33931877 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion-focused training program (EFTP), 10 sessions
Number of subjects: 120
Study 33931877 — intervention group
Group type: COMPARATOR
Intervention: Placebo (interactive activity)
Number of subjects: 120
Study 35896462 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 10 mg
Number of subjects: 98
Study 35896462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 35896462 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C 1000 mg
Number of subjects: 98
Study 32508270 — intervention group
Group type: EXPERIMENTAL
Intervention: Male teacher/male student dyad
Number of subjects: 648
Study 32508270 — intervention group
Group type: EXPERIMENTAL
Intervention: Female teacher/male student dyad
Number of subjects: 648
Study 32508270 — intervention group
Group type: EXPERIMENTAL
Intervention: Female teacher/female student dyad
Number of subjects: 648
Study 32508270 — intervention group
Group type: EXPERIMENTAL
Intervention: Male teacher/female student dyad
Number of subjects: 648
Study 35030255 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus plus prednisolone
Number of subjects: 73
Study 35030255 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus monotherapy
Number of subjects: 73
Study 33843404 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical Rifampin
Number of subjects: 37
Study 33843404 — intervention group
Group type: COMPARATOR
Intervention: Local saline and cefotaxime (Control)
Number of subjects: 37
Study 36107883 — intervention group
Group type: EXPERIMENTAL
Intervention: One-Session Treatment
Number of subjects: 0
Study 36107883 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioural Therapy
Number of subjects: 0
Study 32379556 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone therapy (O3T)
Number of subjects: 6
Study 32665006 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEMg
Number of subjects: 51
Study 32665006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 35156936 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based audiologist-guided CBT
Number of subjects: 158
Study 35156936 — intervention group
Group type: COMPARATOR
Intervention: Weekly monitoring
Number of subjects: 158
Study 33781334 — intervention group
Group type: EXPERIMENTAL
Intervention: Named entity recognition strategy for Spanish medical texts
Number of subjects: 0
Study 33781334 — intervention group
Group type: EXPERIMENTAL
Intervention: Three best neural network architectures tested with MEDDOCAN challenge dataset
Number of subjects: 0
Study 32077730 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion coaching (EC) parenting intervention
Number of subjects: 50
Study 32077730 — intervention group
Group type: EXPERIMENTAL
Intervention: Children of mothers in the EC intervention group
Number of subjects: 50
Study 32077730 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group (control)
Number of subjects: 50
Study 35974379 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle isokinetic rehabilitation programme for 6 weeks (at least 25 sessions)
Number of subjects: 60
Study 35974379 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation for 6 weeks
Number of subjects: 60
Study 33975925 — intervention group
Group type: EXPERIMENTAL
Intervention: CALLS intervention (12-weekly phone sessions with patient navigator)
Number of subjects: 30
Study 33975925 — intervention group
Group type: COMPARATOR
Intervention: Usual care control condition
Number of subjects: 30
Study 32666402 — intervention group
Group type: COMPARATOR
Intervention: Brexanolone injection (not specified dosage or duration)
Number of subjects: 0
Study 36174629 — intervention group
Group type: EXPERIMENTAL
Intervention: Niraparib plus nivolumab
Number of subjects: 0
Study 36174629 — intervention group
Group type: EXPERIMENTAL
Intervention: Niraparib plus ipilimumab (3 mg/kg intravenously every 3 weeks for four doses)
Number of subjects: 0
Study 33011429 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality training with a VR image of walking through narrow apertures.
Number of subjects: 25
Study 33011429 — intervention group
Group type: COMPARATOR
Intervention: Control group walking through a wide aperture without body rotation.
Number of subjects: 25
Study 34991364 — intervention group
Group type: COMPARATOR
Intervention: Proposed interventional treatment in a double-blinded, randomized, placebo-controlled clinical trial
Number of subjects: 875
Study 32633040 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-mm inter-implant distance
Number of subjects: 30
Study 32633040 — intervention group
Group type: COMPARATOR
Intervention: 3-mm inter-implant distance
Number of subjects: 30
Study 34210725 — intervention group
Group type: COMPARATOR
Intervention: CM Attendance
Number of subjects: 552
Study 34210725 — intervention group
Group type: COMPARATOR
Intervention: CM Abstinence
Number of subjects: 552
Study 34910380 — intervention group
Group type: EXPERIMENTAL
Intervention: BSC plus a 10% urea‐based cream
Number of subjects: 129
Study 34910380 — intervention group
Group type: EXPERIMENTAL
Intervention: BSC plus a moisturising cream
Number of subjects: 129
Study 34910380 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care (BSC)
Number of subjects: 129
Study 33291020 — intervention group
Group type: EXPERIMENTAL
Intervention: Swaddled
Number of subjects: 40
Study 33291020 — intervention group
Group type: COMPARATOR
Intervention: Non-swaddled
Number of subjects: 40
Study 33291020 — intervention group
Group type: EXPERIMENTAL
Intervention: Swaddled and Non-swaddled
Number of subjects: 40
Study 32061969 — intervention group
Group type: EXPERIMENTAL
Intervention: AFL intervention (12 weeks of semiweekly sports skill programming and nutrition sessions for children; sports-focused activity and behavior change sessions for parents)
Number of subjects: 160